Skip to main content
Cresco Labs Inc. logo

Cresco Labs Inc. — Investor Relations & Filings

Ticker · CRLBF ISIN · CA22587M1068 LEI · 549300NSGBTQRF1IBL30 CSE Manufacturing
Open in API
Filings indexed 386 across all filing types
Latest filing 2021-03-27 Regulatory Filings
Country CA Canada
Listing CSE CRLBF

About Cresco Labs Inc.

https://www.crescolabs.com/

Cresco Labs Inc. is a vertically integrated, multistate operator in the cannabis industry, specializing in the cultivation, manufacturing, distribution, and retail sale of medical and adult-use cannabis products. The company manages a portfolio of proprietary brands, including Cresco Cannabis, High Supply, and Mindys Edibles, offering various formats such as flowers, concentrates, and edibles. Cresco Labs distributes its products wholesale and through its national dispensary network, primarily branded Sunnyside, across the United States and Germany. The company focuses on professionalizing the cannabis experience, maintaining high-quality production standards, and promoting industry responsibility through advocacy and community initiatives.

Recent filings

Filing Released Lang Actions
Annual information form - English.pdf
Regulatory Filings Classification · 90% confidence The document is titled 'Annual Information Form' for the year ended December 31, 2020, dated March 26, 2021. It contains detailed sections such as corporate structure, business description, risk factors, dividends, capital structure, directors and officers, legal proceedings, and auditor information. It references audited consolidated financial statements and management's discussion and analysis (MD&A) but does not itself contain the full financial statements. The document is comprehensive and lengthy (15,000 characters), indicating it is a substantive report rather than a brief announcement. An Annual Information Form (AIF) is a detailed disclosure document commonly filed in Canada, providing extensive information about the company, its business, risks, and governance, but it is distinct from the Annual Report (10-K) which includes full financial statements. Given the nature and content, the best fitting category is Regulatory Filings (RNS) as the AIF is a regulatory disclosure document that does not constitute the full Annual Report (10-K).
2021-03-27 English
Annual MD&A - English.pdf
Management Reports Classification · 100% confidence The document is titled 'Management’s Discussion and Analysis of Financial Condition and Results of Operations for the Three Months and Years Ended December 31, 2020 and 2019,' which clearly indicates it is a Management Discussion and Analysis (MD&A) report. It contains detailed financial condition and operational results analysis for specific fiscal periods, including both quarterly and annual data. The text references IFRS financial statements, non-IFRS measures, and forward-looking statements, all typical of an MD&A. It also discusses recent financing activities and corporate structure but the primary content is management's detailed explanation of financial results and business trends. The document length is substantial (15,000 characters), indicating it is the report itself, not just an announcement. Therefore, the appropriate classification is Management Reports (MDA).
2021-03-27 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 13-501F1' and is described as a 'Management Certification' submitted to the Alberta Securities Commission. It contains detailed market value calculations of listed equity securities over specified trading periods within a financial year ending December 31, 2020. The document is a certification by an officer (Chief Financial Officer) attesting to the completeness and accuracy of the information provided. There are no financial statements, management discussion, or detailed financial results presented. The primary content is a certification related to reporting issuer participation fees and market value calculations, not a full financial report or earnings release. Given the nature of the document as a certification submitted to a regulatory body, it fits best under Regulatory Filings (RNS) rather than a full Annual Report, Interim Report, or other financial report types.
2021-03-27 English
Audited annual financial statements – English.pdf
Annual Report Classification · 98% confidence The document is titled 'CRESCO LABS INC. CONSOLIDATED FINANCIAL STATEMENTS AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2020 AND 2019' and includes detailed consolidated financial statements such as statements of financial position, operations, comprehensive loss, changes in shareholders' equity, cash flows, and extensive notes. It also contains an Independent Auditor's Report with an opinion on the consolidated financial statements. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of full financial statements and auditor's report for a full fiscal year strongly indicates this is an Annual Report. The document does not appear to be just an audit report alone, but the full annual financial report including management responsibility statements and notes. Therefore, the appropriate classification is Annual Report (10-K). FY 2020
2021-03-27 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings Classification · 100% confidence The document is a Form 13-502F1 related to Class 1 and Class 3B reporting issuers, specifically concerning the participation fee calculation under OSC Rule 13-502 Fees. It includes management certification by an officer, detailed market value calculations of equity securities for specified trading periods, and the resulting participation fee payable. There are no financial statements, earnings data, or management discussion of results. The document is a regulatory filing related to fee reporting and certification to the Ontario Securities Commission. It is not an annual report, audit report, earnings release, or any other financial report type. It is a regulatory compliance filing with certification and fee calculation information, fitting best under Regulatory Filings (RNS).
2021-03-27 English
News release - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a detailed financial release from Cresco Labs announcing their fourth quarter and full year 2020 results. It includes comprehensive financial data such as revenue, adjusted EBITDA, operating cash flow, balance sheet details, and management commentary. The document also references unaudited management-prepared financial statements and mentions the upcoming filing of audited consolidated financial statements. The length of the document (15,000 characters) and the presence of substantive financial data and analysis indicate this is a full financial report rather than a brief earnings release or announcement. The content aligns with a comprehensive annual report or a detailed earnings report for the full fiscal year. Given the detailed financial statements and management discussion, this document best fits the category of an Interim / Quarterly Report (IR) because it covers the full year 2020 results but is unaudited and presented as a quarterly/fiscal period report rather than a formal Annual Report (10-K). However, since it covers the full year and includes detailed financial statements and analysis, it is more comprehensive than a typical quarterly earnings release (ER). The document is not an announcement of a report publication (RPA) because it contains the actual financial data, not just a notice. Therefore, the most appropriate classification is Interim / Quarterly Report (IR). FY 2020
2021-03-25 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.